BRIEF-Janssen inc- Health Canada has approved Invega Trinza 

Mon Jun 27, 2016 7:29am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 27 (Reuters) - Janssen Inc

* Health Canada has approved Invega Trinza  (paliperidone palmitate), an antipsychotic medication for schizophrenia

* Health Canada's approval of Invega Trinza  is based on two randomized, double-blind trials

* Invega Trinza provides a new dosing regimen option administered only four times a year Source text for Eikon: Further company coverage: